Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Aug;48(4):647-651.
doi: 10.1007/s15010-020-01458-9. Epub 2020 Jun 13.

Successful management of the first reported case in Austria of COVID-19 with ARDS

T Seitz  1 , W Hoepler  2 , L Weseslindtner  3 , J H Aberle  3 , S W Aberle  3 , E Puchhammer-Stoeckl  3 , S Baumgartner  2 , M Traugott  2 , M Karolyi  2 , E Pawelka  2 , I Niculescu  2 , E Friese  2 , S Neuhold  2 , D Stahl  4 , C Madl  5 , A Zoufaly  2 , C Wenisch  2 , H Laferl  2
Affiliations
Case Reports

Successful management of the first reported case in Austria of COVID-19 with ARDS

T Seitz et al. Infection. 2020 Aug.

Abstract

We report the successful management of a patient with severe respiratory failure due to COVID-19 admitted to an intensive care unit complicated by secondary catheter-related infection of Candida glabrata. We are discussing some of the clinical challenges and the pitfalls in molecular diagnosis of SARS-CoV-2, including the fact that a positive PCR result may not always reflect infectiousness.

Keywords: ARDS; COVID-19; Candida glabrata; Candidemia; SARS-CV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
CT-scan 11 days after illness onset. Massive pneumonic consolidations in all lung lobes
Fig. 2
Fig. 2
CT-scan 21 days after illness onset. Significant reduction of pneumonic consolidations and improvement of signs of ARDS
Fig. 3
Fig. 3
Summary of clinical course
See this image and copyright information in PMC

References

    1. World Health Organization. Novel coronavirus—China. 2020. http://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. Accessed 12 Apr 2020.
    1. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect. 2020 doi: 10.1016/j.ijid.2020.03.053. - DOI
    1. Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020 doi: 10.1136/bmj.m1198. - DOI - PubMed
    1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 doi: 10.1016/S0140-6736(20)30566-3. - DOI - PMC - PubMed
    1. Lamers MM, Beumer J, et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020 doi: 10.1126/science.abc1669. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources